Skip to main content
Fig. 6 | Cell & Bioscience

Fig. 6

From: Dapagliflozin attenuates hypoxia/reoxygenation-caused cardiac dysfunction and oxidative damage through modulation of AMPK

Fig. 6

Anti-apoptotic effect of dapagliflozin (DAPA) on ischemia/reperfusion injured animals.

Representative images of TUNEL staining of the cardiac tissues (a) and quantification of the apoptotic areas (b) were shown. The plasma concentration of myocardial damage markers, lactate dehydrogenase (LDH) (c) and creatine kinase-MB (CK-MB) (d), in control animals and ischemia/reperfusion (I/R) animals with or without DAPA treatment were checked. The data were presented as the mean ± SD of eight animals in each group. (* indicating p < 0.05 compared with the control group; # indicating p < 0.05 compared to I/R without DAPA treatment)

Back to article page

Cell & Bioscience

ISSN: 2045-3701

Contact us